We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Mylan IRE Healthcare Limited

Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland
Medical Information Direct Line: +44 (0)1707 853000 press 1
Medical Information e-mail: info@mylan.co.uk
Patient Information Leaflet last updated on medicines.ie: 14/12/2017
PIL Teveten Plus 600mg/12.5mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 14/12/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision
Updated on 30/06/2017 and displayed until 14/12/2017
Reasons for adding or updating:
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision
Updated on 26/09/2016 and displayed until 30/06/2017
Reasons for adding or updating:
  • Change of distributor details
Updated on 26/05/2016 and displayed until 26/09/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to further information section
  • Change to date of revision
Updated on 25/08/2015 and displayed until 26/05/2016
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 30/03/2015 and displayed until 25/08/2015
Reasons for adding or updating:
  • Change to marketing authorisation holder
Updated on 26/02/2015 and displayed until 30/03/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to drug interactions
Updated on 14/08/2014 and displayed until 26/02/2015
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 23/07/2014 and displayed until 14/08/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Addition of information on reporting a side effect.
Updated on 30/01/2014 and displayed until 23/07/2014
Reasons for adding or updating:
  • Change of trade or active ingredient name
  • Change to date of revision
Updated on 07/02/2013 and displayed until 30/01/2014
Reasons for adding or updating:
  • Change of manufacturer
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about driving or using machinery
  • Change to further information section
  • Change to dosage and administration
  • Change to improve clarity and readability
  • Change due to user-testing of patient information
Updated on 17/11/2011 and displayed until 07/02/2013
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 05/04/2011 and displayed until 17/11/2011
Reasons for adding or updating:
  • Change to further information section
  • Change to date of revision
  • Change to appearance of the medicine
Updated on 16/06/2010 and displayed until 05/04/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to information about pregnancy or lactation
  • Change to marketing authorisation holder
  • Change to name of manufacturer
Updated on 06/07/2007 and displayed until 16/06/2010
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 26/05/2006 and displayed until 06/07/2007
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 02/05/2006 and displayed until 26/05/2006
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 03/06/2005 and displayed until 02/05/2006
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Hydrochlorothiazide
   Eprosartan mesilate